Seeing Is Believing
Currently out of the existing stock ratings of Samuel Brodovsky, 15 are a BUY (57.69%), 11 are a HOLD (42.31%).
Analyst Samuel Brodovsky, currently employed at TRUIST, carries an average stock price target met ratio of 75.4% that have a potential upside of 19.78% achieved within 83 days.
Samuel Brodovsky’s has documented 52 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GKOS, Glaukos Corp at 16-Jul-2024.
Analyst best performing recommendations are on VCEL (VERICEL CORP ORD).
The best stock recommendation documented was for VCEL (VERICEL CORP ORD) at 1/31/2023. The price target of $29 was fulfilled within 2 days with a profit of $1.53 (5.57%) receiving and performance score of 27.85.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$42
$19.07 (83.17%)
$42
13 days ago
(08-Nov-2024)
6/16 (37.5%)
$16.28 (63.30%)
172
Hold
$28
$5.07 (22.11%)
$34
1 months 7 days ago
(14-Oct-2024)
3/7 (42.86%)
$2.05 (7.90%)
26
Buy
$50
$27.07 (118.05%)
$50
2 months 8 days ago
(13-Sep-2024)
2/11 (18.18%)
$17.72 (54.89%)
58
Hold
$35
$12.07 (52.64%)
$38
4 months 5 days ago
(16-Jul-2024)
2/6 (33.33%)
$-0.36 (-1.02%)
47
Buy
$34
$11.07 (48.28%)
$50
8 months 14 days ago
(07-Mar-2024)
6/6 (100%)
$5.27 (18.34%)
89
Which stock is Samuel Brodovsky is most bullish on?
Which stock is Samuel Brodovsky is most reserved on?
What Year was the first public recommendation made by Samuel Brodovsky?